Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy
Top Cited Papers
Open Access
- 10 February 2000
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 342 (6) , 365-373
- https://doi.org/10.1056/nejm200002103420601
Abstract
Hypertrophic cardiomyopathy is a genetic disease associated with a risk of ventricular tachyarrhythmias and sudden death, especially in young patients.Keywords
This publication has 40 references indexed in Scilit:
- Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathyJournal of the American College of Cardiology, 1999
- Impact of Laboratory Molecular Diagnosis on Contemporary Diagnostic Criteria for Genetically Transmitted Cardiovascular Diseases: Hypertrophic Cardiomyopathy, Long-QT Syndrome, and Marfan SyndromeCirculation, 1998
- Prospective Prognostic Assessment of Blood Pressure Response During Exercise in Patients With Hypertrophic CardiomyopathyCirculation, 1997
- Hypertrophic cardiomyopathyThe Lancet, 1997
- The Management of Hypertrophic CardiomyopathyNew England Journal of Medicine, 1997
- Hypertrophic CardiomyopathyCirculation, 1995
- Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia.Circulation, 1994
- Hypertrophic cardiomyopathyProgress in Cardiovascular Diseases, 1994
- Hypertrophic CardiomyopathyNew England Journal of Medicine, 1987
- Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A reviewProgress in Cardiovascular Diseases, 1985